insights_auto
Why is AGIO down 2.77%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
$31.91
arrow_downward
-2.77%(-0.91) 1D
Nov 12, 1:17:33 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$32.56
High
$32.76
Low
$31.66
Mkt. cap
1.91B
Avg. vol.
1.29M
Volume
150.63K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
Open
$32.56
High
$32.76
Low
$31.66
Mkt. cap
1.91B
Avg. vol.
1.29M
Volume
150.63K
52-wk high
$45.99
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
News stories
From web sources and news partners
TradingView
·
3 days ago
Weekly Recap: Q3 product revenue rises and FDA delays mitapivat review
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc